Navigation Links
Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
Date:6/4/2008

MOORESVILLE, N.C., June 4 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly owned subsidiary, EnviroSystems, Inc. (ESI) announced that the U.S. Environmental Protection Agency (EPA) accepted its submission to add additional claims to its disinfectant/sanitizer, EnviroTru(R) for use of the product as a sanitizer against the "superbug" MRSA (scientifically known as Methicillin Resistant Staphylococcus aureus) and VRE (scientifically known as Vancomycin Resistant Enterococcus faecalis). Having received approval from the federal EPA for these additional claims, the company has commenced the state registration process which it believes should be completed with the majority of states within 30 days.

EnviroTru(R) ( http://www.envirosi.com/products/envirotru.htm ) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner, effective against numerous organisms, and also meets EPA requirements for Toxicity Category IV (no harmful dermal, ocular, inhalation or ingestion effects). EnviroTru(R) does not require protective clothing, gloves or special ventilation and has passed the AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for non-corrosion and materials compatibility.

J. Lloyd Breedlove, President and CEO of Anpath Group, stated, "We are confident these additional claims will add to the growing market demand for EnviroTru(R). The timeliness of this registration is noteworthy considering the increased incidence of MRSA cases reported in public settings; particularly schools." Mr. Breedlove continued, "These claims are a small part of our aggressive development and testing program intended to expand our product offering. Moreover, while the ability to kill potentially harmful microorganisms is important, it is just as important that the biocide have a favorable profile for health and environmental effects. It is no
'/>"/>

SOURCE Anpath Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
2. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
3. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
4. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
5. Wound Management Technologies, Inc. Announces Evidence Based Study
6. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
7. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
8. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
9. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
10. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
11. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...tCall/ -- Boston Scientific Corporation (NYSE: BS...nt in principle with the U.S. Department of Justic...s Guidant subsidiary in 2005. The alleged conduct...ific,s 2006 acquisition of Guidant. ,, Boston S...n by the U.S. Attorney,s Office in Minneapolis int...
(Date:11/6/2009)...l/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a ...f small-molecule therapeutics for the treatment of...V), today reported recent accomplishments and fina...s ended September 30, 2009. ,, (Logo: http:/... ,, "Since our last quarterly update, we have c...
(Date:11/6/2009)... -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ...opharmaceutical company developing human vaccines ...cy Virus) and other infectious agents, today annou...provided an operational update. ,, Robert McNal...ommented, "We are pleased with our progress during...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 1Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 2Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 3Underweight and Extremely Obese Die Earlier Than People of Normal Weight Study Finds 49807 4Determining Who Will Respond to Brain Tumor Therapy 49802 1A Canada wide technology platform for mapping the human interactome 8974 1A Canada wide technology platform for mapping the human interactome 8974 2
...HINGTON, Oct. 22 Today, the American,Society of H...al Oncology,(ASCO) have released an updated joint ... agents (ESAs), a class of drugs that stimulate,th...treat,chemotherapy-related anemia., "One goal of ...most,up-to-date evidence from high-quality studies...
...ICIA, Calif., Oct. 22 AcroMetrix, the leading,pro...agnostic and blood,testing laboratories, announced...ntification Panel to be the first to utilize an ED...is for Research Use Only, not for use in,diagnosti... allows the OptiQuant HIV-1 panel to,most closely ...
Other Medicine Technology:ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel 2
(Date:11/7/2009)...swire-USNewswire/ -- Karen Ignagni, President and ...leased the following statement today on House pass...port comprehensive health care reform, and we have...plete overhaul of how health insurance is provided...ge, elimination of pre-existing condition exclusio...
(Date:11/7/2009)...ire-USNewswire/ -- The American Medical Associatio... for Citizenship and Community Service to Manus C.... The award recognizes physicians who have gone abo...ake an outstanding public service contribution to ...d today during the opening session of the 2009 Int...
(Date:11/7/2009)...), David A. Cook (GA), Louis J. Goodman (TX), Palm..., CHICAGO, Nov. 7 The...d five medical society executive leaders with achi... goals and ideals of the medical profession. The a...cy making meeting in Houston. ,, (Logo: http...
(Date:11/7/2009)...re-USNewswire/ -- Members of the AMA are trying a ...ution rescinding the AMA,s support of HR 3962. ,...sponsible to their PATIENTS, not the leadership of... for the Association of American Physicians and Su...er medical groups. ,, "If the AMA leadership i...
(Date:11/7/2009)...ics have a responsibility to vigorously oppose abo..." ,, WASHINGTON, Nov. 7 /PRNewswire-USNewsw...n released the following statement on the news tha...y Pelosi,s Affordable Health Care for America Act ...status quo for abortion is voted upon. ,, "Our...
Breaking Medicine News(10 mins):Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...ch day more consumers are turning to webLAB to sav...tests online. Physicians Wellness Network (PWN) t... and trend their webLAB test results in their Micr...ation. , Jackson, WY (PRW...
...re-FirstCall/ - Transition Therapeutics Inc. ("Tra...H) announced today that the first patient has been...223 in combination with a proprietary Lilly GLP-1 ...e the safety, tolerability and efficacy of daily T...
...s to tell the story of leader in senior assisted l...e Highlands , the largest Continuing Care Retireme... WordWrite Communications as its agency of record... the quality living alternatives and services Reds...
...oRelix, pioneers in the discovery and development ... Medicinal Chemistry have jointly announced an exp...llaboration and agreement to discover and develop ...opment of Riboswitch based therapeutic agents, and...
...gent care provider NextCare continues its commitme...communities from six immediate care clinic locatio... March 23, 2009 -- Urgent care provider NextCare (... a location in Highlands Ranch coming in June, Nex...
...Telecare Corporation has appointed Pat Doyle to Vi...s new position, Doyle will focus on expanding Tele...managing acute psychiatric care services. Prior t...t Horizon Health Corporation. , , "Hospitals fre...
Other Medicine News:Health News:PWN Announces That Consumers Can Now Store webLAB Test Results In Their Microsoft HealthVault Account 2Health News:PWN Announces That Consumers Can Now Store webLAB Test Results In Their Microsoft HealthVault Account 3Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2Health News:Redstone Highlands Names WordWrite Communications Agency of Record 2Health News:BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches 2Health News:Three New NextCare Immediate Care Clinic Locations Open in Colorado 2
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
... Endotracheal Tubes offer the features needed by t...ctile feedback from pilot balloon , Thermosensitiv...e , Smooth tube tip, molded and gently cupped to m...ff types: High Volume Tapered (HVT) and Close Fitt...
Bougie - Disposable
Microcuff Adult (ICU) Tracheal Tubes
Medicine Products: